Physician profile
Joe W Chamberlin
NPI 1912103227
$3,574.65
in general payments reported to CMS, 2019-2025
20 companies · $86.57 in 2025
The $86.57 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $557 · 2021: $962 · 2022: $643 · 2023: $372 · 2024: $227 · 2025: $86.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,250.86 | 2019-2025 | Rybelsus, Ozempic |
| Horizon Therapeutics Plc | $508.43 | 2019-2023 | Pennsaid |
| Astrazeneca Pharmaceuticals Lp | $346.77 | 2019-2024 | Fasenra, Farxiga |
| Lilly USA, LLC | $253.50 | 2020-2024 | Mounjaro, Zepbound |
| Scilex Pharmaceuticals INC. | $222.77 | 2020-2023 | Ztlido |
| Glaxosmithkline, LLC. | $134.93 | 2019-2024 | Bexsero, Arexvy, Shingrix |
| Mannkind Corporation | $123.66 | 2019-2020 | |
| Astellas Pharma US INC | $111.50 | 2023-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $107.47 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $71.36 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.09 | 2019-2021 | |
| Corcept Therapeutics | $70.50 | 2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $63.72 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.17 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $49.02 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $41.98 | 2021-2022 | |
| Pfizer INC. | $35.99 | 2021 | |
| Exact Sciences Corporation | $23.22 | 2023 | Cologuard Collection Kit |
| Redhill Biopharma INC. | $16.67 | 2020 | |
| Abbvie INC. | $15.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Chamberlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.